1. GPCR/G Protein
  2. P2Y Receptor
  3. MRS4917

MRS4917 是一种口服有效的强效选择性 P2Y14 受体 (hP2Y14R) 拮抗剂 (IC50 = 2.88 nM,Ki = 1.67 nM),其对 P2Y6R 具有超过 18000 倍的选择性 (IC50 = 54 μM)。MRS4917 经口服给药后,可有效逆转慢性坐骨神经压迫 (CCI) 小鼠模型中已形成的机械性痛觉超敏,同时不影响体温调节。MRS4917 可用于神经系统疾病研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

MRS4917

MRS4917 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

MRS4917 is an orally active, potent selective P2Y14 receptor (hP2Y14R) antagonist (IC50 = 2.88 nM, Ki = 1.67 nM) that shows >18,000 fold selectivity against P2Y6R (IC50 = 54 μM). MRS4917 demonstrates oral efficacy in reversing established mechanoallodynia in the chronic constriction injury (CCI) mouse model, while having no effect on thermoregulation. MRS4917 can be used for neurological diseases research[1].

IC50 & Target[1]

hP2Y14R

2.88 nM (IC50)

P2Y6 Receptor

54 μM (IC50)

体外研究
(In Vitro)

MRS4917 (compound 11) (0.1-10 μM, 72 小时) 在体外展现出良好的安全性,包括低细胞毒性、对 CYP450 酶 (CYP2D6CYP3A4) 无显著抑制、并且在广泛的脱靶筛选中显示出高选择性 (仅微弱作用于 α2C 受体)[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: HepG2 and SH-SY5Y cells
Concentration: 0.1-10 μM
Incubation Time: 72 h
Result: Showed low cytotoxicity (18 % growth inhibition) in HepG2 cells at 10 μM.
Induced a slight growth-promoting effect (15 % increase) in SH-SY5Y cells at 10 μM.
体内研究
(In Vivo)

MRS4917 (1.37 mg/kg 单次口服,或 4.58 mg/kg 单次腹腔注射) 可减轻慢性坐骨神经压迫 (CCI) 小鼠模型中的机械性异常疼痛[1]
MRS4917 (10 mg/kg,单次腹腔注射) 对野生型 C57BL/6J 小鼠的体温或自主活动均无影响[1]
MRS4917 (10 mg/kg, 腹腔注射,于 MRS2905 给药前 60 分钟注射) 可有效阻断 P2Y14R 激动剂 MRS2905 (5 mg/kg,腹腔注射) 在雄性C57BL/6J小鼠中诱导的低体温效应[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Wild-type C57BL/6J male mice[1]
Dosage: 10 mg/kg
Administration: i.p., single dose
Result: Showed no significant effect on core body temperature.
Induced no significant changes in locomotor activity.
Animal Model: Adult male ICR mice with CCI of the left sciatic nerve (Bennett method)[1]
Dosage: 1.37 mg/kg (p.o.) and 4.58 mg/kg (i.p.)
Administration: p.o. and i.p., single dose
Result: Reached full efficacy within 1 hour after both oral and i.p. administration, and maintained this effect over a prolonged period.
The lower oral dose achieved comparable in vivo efficacy to the higher i.p. dose.
Showed no effect on the contralateral (control) paw.
Animal Model: Wild-type C57BL/6J male mice[1]
Dosage: 10 mg/kg
Administration: i.p., 60 min before MRS2905 (5 mg/kg, i.p.)
Result: Blocked the hypothermic effect induced by the P2Y14R agonist MRS2905.
分子量

458.43

Formula

C27H17F3N2O2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
MRS4917
目录号:
HY-178006
需求量: